Publications

July 2002
Article

Asset Accumulation, Interdependence and Technological Change: Evidence from Pharmaceutical Drug Discovery

By: Stefan Thomke and Walter Kuemmerle

Keywords: Assets; Information Technology; Change; Health

April 2002
Case

In vivo to in vitro to in silico: Coping with Tidal Waves of Data at Biogen

By: Juan Enriquez-Cabot, Gary P. Pisano and Gaye Bok

Biogen is a successful biotech company facing a critical juncture. CEO John Mullen ponders how technological changes introduced into the research function will shape larger corporate decisions. This world in which biotechnology companies operated had changed... View Details

Keywords: Change; Decisions; Product Development; Research and Development; Expansion; Technology; Biotechnology Industry

Educators

Purchase

2001
Working Paper

Asset Accumulation, Interdependence and Technological Change: Evidence from Pharmaceutical Drug Discovery

By: Stefan Thomke and Walter Kuemmerle

2000
Chapter

Measuring Competence? Exploring Firm Effects in Drug Discovery

By: Rebecca M. Henderson and Iain Cockburn

Keywords: Competency and Skills; Measurement and Metrics; Research and Development; Innovation and Invention; Pharmaceutical Industry

Article

Strategic Assets, Interdependence and Technological Change: An Empirical Investigation of Complementarity in Pharmaceutical Drug Discovery

By: S. Thomke and W. Kuemmerle

Keywords: Strategy; Assets; Information Technology; Change; Information; Health; Pharmaceutical Industry

1999
Chapter

The Economics of Drug Discovery

By: Rebecca M. Henderson and Iain Cockburn

Keywords: Economics; Innovation and Invention; Research and Development; Pharmaceutical Industry

Article

Absorptive Capacity, Coauthoring Behavior, and the Organization of Research in Drug Discovery

By: Rebecca M. Henderson and Iain Cockburn

Keywords: Behavior; Research and Development; Organizations; Health

October 1997 (Revised September 2003)
Case

Eli Lilly and Company: Drug Development Strategy (A)

By: Stefan H. Thomke, Ashok Nimgade and Paul Pospisil

Describes how Eli Lilly and Co. tries to accelerate its new drug development process with the aid of "combinatorial chemistry"--a rapidly emerging and revolutionary approach to preclinical drug discovery. The product manager of a potential blockbuster migraine drug... View Details

Keywords: Chemicals; Finance; Innovation and Invention; Time Management; Markets; Product Development; Organizations; Business Processes; Problems and Challenges; Business and Stakeholder Relations; Competition; Pharmaceutical Industry

Educators

Purchase

1996
Chapter

The Determinants of Research Productivity in Ethical Drug Discovery

By: Rebecca M. Henderson and Ian Cockburn

Keywords: Ethics; Health Testing and Trials; Research and Development; Performance Productivity; Pharmaceutical Industry

spring 1996
Article

Scale, Scope and Spillovers: The Determinants of Research Productifity in Drug Discovery

By: Rebecca M. Henderson and Ian Cockburn

Keywords: Research; Product; Health

fall 1994
Article

Racing to Invest? The Dynamics of Competition in Ethical Drug Discovery

By: Rebecca M. Henderson and Ian Cockburn

Keywords: Investment; Competition; Ethics; Health

Article

Measuring Competence? Exploring Firm Effects in Drug Discovery

By: Rebecca M. Henderson and Ian Cockburn

Keywords: Measurement and Metrics; Competency and Skills; Health

1994
Article

The Evolution of Integrative Capability: Innovation in Cardiovascular Drug Discovery

By: Rebecca M. Henderson

Keywords: Innovation and Invention; Health; Integration